Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan Drug Designation for QIXLEEF.
Malta’s Minister for Reform, Owen Bonnici has tabled the first reading of the government’s proposed cannabis reforms.
Grow and Sanoid aim to supply high quality cannabis products at an affordable price point for patients.
Apeiron Investment Group is now the largest shareholder of European cannabis company SynBiotic.
Materia announced that its wholly-owned subsidiary, Materia Malta, has received the licence from the Malta Medicines Authority.
Motagon says the import is a unique medical cannabis frontier with immense potential.
Italy could join Austria and Cyprus as one of the only countries to allow home cultivation for medicinal use.
The company is looking forward to beginning products sales designed for the Oncology field in partnership with the German company, Axio-Novo, this year.
The Cannabis Society is to host a conference this September that will discuss both European medical cannabis and North American multi-state operators (MSO) growth and consolidation.
The move will see Flora’s finished cannabis products reach patients in Europe.